Therefore, our findings reinforce the suggestion that both downregulation of DARPP-32 and upregulation of NCS-1 reported to occur in the PFC of schizophrenia patients, might be associated with the psychopathology of the disorder but not with antipsychotic treatment (Figure 3). Here, NCS1 is linked to schizophrenia.